Lorrie M. Norrington
Lorrie M. Norrington's purchase track record
Lorrie M. Norrington has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/11/2026 | HUBS | $250K | +12.8% | pending | — |
| 12/6/2021 | ASAN | $248K | -35.7% | -66.6% | -10.2% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
HubSpot Faces Analyst Downgrades Amid Market Pressure. Several analysts have lowered their outlook on HubSpot, including a recent downgrade by Raymond James to market‑perform. The change follows a broader trend of tech stocks moving lower in Monday’s pre‑market session. HubSpot’s price is near a key support level of $210.42, adding pressure on the stock.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
Asana featured in profit, board and share-price news. Recent coverage highlighted Asana as one of three unprofitable stocks discussed in a Yahoo analysis. Another Yahoo piece examined the company’s new AI‑focused board and considered whether it signals more innovation or tighter control. After‑hours trading reports and other Yahoo articles noted that Asana’s shares moved higher alongside other tech names, drawing market attention to its performance and governance changes.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
ADSK Growth Trajectory and Market Pullback in Focus. Recent news highlights Autodesk's market pullback and debates over whether it remains a top play on fast software growth. Articles compare its cloud and AI investments to peers like Adobe and PTC, questioning future earnings acceleration. This divided outlook is reflected in analyst targets spanning $215.00 to $375.00, as the stock trades within its $185.50 to $320.00 range.
Transaction History
| CL | ▲ Buy | Grant | 293 | $26K | 7/1/2026 | View on chart |
| HUBS | ▲ Buy | Grant | 1,211 | $0 | 6/16/2026 | View on chart |
| HUBS | ▲ Buy | Open Market | 1,313 | $250K | 5/11/2026 | View on chart |
| CL | ▲ Buy | Grant | 2,075 | $0 | 5/11/2026 | View on chart |
| ASAN | ▲ Buy | Grant | 2,323 | $0 | 5/1/2026 | View on chart |
| CL | ▲ Buy | Grant | 294 | $26K | 4/1/2026 | View on chart |
| ASAN | ▲ Buy | Grant | 1,432 | $0 | 2/2/2026 | View on chart |
| CL | ▲ Buy | Grant | 333 | $26K | 1/2/2026 | View on chart |
| ASAN | ▲ Buy | Grant | 1,045 | $0 | 11/3/2025 | View on chart |
| CL | ▲ Buy | Grant | 319 | $26K | 10/1/2025 | View on chart |
| ASAN | ▲ Buy | Grant | 1,001 | $0 | 8/1/2025 | View on chart |
| CL | ▲ Buy | Grant | 292 | $26K | 7/1/2025 | View on chart |
| ASAN | ▲ Buy | Grant | 13,089 | $0 | 6/16/2025 | View on chart |
| HUBS | ▲ Buy | Grant | 400 | $0 | 6/4/2025 | View on chart |
| CL | ▲ Buy | Grant | 2,019 | $0 | 5/12/2025 | View on chart |
| ASAN | ▲ Buy | Grant | 910 | $0 | 5/1/2025 | View on chart |
| CL | ▲ Buy | Grant | 258 | $24K | 4/1/2025 | View on chart |
| ASAN | ▲ Buy | Grant | 688 | $0 | 2/3/2025 | View on chart |
| CL | ▲ Buy | Grant | 281 | $26K | 1/2/2025 | View on chart |
| HUBS | ▼ Sell | Open Market | 572 | $413K | 12/27/2024 | View on chart |
| HUBS | ▼ Sell | Open Market | 572 | $395K | 12/20/2024 | View on chart |
| ADSK | ▼ Sell | Open Market | 1,778 | $543K | 12/11/2024 | View on chart |
| ADSK | ▼ Sell | Open Market | 1,778 | $544K | 12/6/2024 | View on chart |
| ASAN | ▲ Buy | Grant | 1,230 | $0 | 11/1/2024 | View on chart |
| CL | ▲ Buy | Grant | 249 | $26K | 10/1/2024 | View on chart |
| ASAN | ▲ Buy | Grant | 1,009 | $0 | 8/1/2024 | View on chart |
| ADSK | ▲ Buy | Grant | 401 | $0 | 7/16/2024 | View on chart |
| ADSK | ▲ Buy | Grant | 984 | $0 | 7/16/2024 | View on chart |
| CL | ▲ Buy | Grant | 274 | $26K | 7/1/2024 | View on chart |
| ASAN | ▲ Buy | Grant | 14,583 | $0 | 6/17/2024 | View on chart |
| HUBS | ▲ Buy | Grant | 412 | $0 | 6/11/2024 | View on chart |
| CL | ▲ Buy | Grant | 1,905 | $0 | 5/13/2024 | View on chart |
| ASAN | ▲ Buy | Grant | 988 | $0 | 5/1/2024 | View on chart |
| CL | ▲ Buy | Grant | 297 | $26K | 4/1/2024 | View on chart |
| ASAN | ▲ Buy | Grant | 845 | $0 | 2/1/2024 | View on chart |
| CL | ▲ Buy | Grant | 335 | $26K | 1/2/2024 | View on chart |
| HUBS | ▼ Sell | Open Market | 350 | $175K | 11/30/2023 | View on chart |
| CL | ▲ Buy | Option Exercise | 6,329 | $393K | 11/2/2023 | View on chart |
| CL | ▼ Sell | Open Market | 6,329 | $472K | 11/2/2023 | View on chart |
| ASAN | ▲ Buy | Grant | 796 | $0 | 11/1/2023 | View on chart |
| CL | ▲ Buy | Grant | 360 | $26K | 10/2/2023 | View on chart |
| ADSK | ▼ Sell | Open Market | 2,148 | $450K | 9/29/2023 | View on chart |
| ASAN | ▲ Buy | Grant | 604 | $0 | 8/1/2023 | View on chart |
| CL | ▲ Buy | Grant | 343 | $26K | 7/3/2023 | View on chart |
| ASAN | ▼ Sell | Open Market | 3,733 | $90K | 6/21/2023 | View on chart |
| ADSK | ▲ Buy | Grant | 490 | $0 | 6/21/2023 | View on chart |
| ADSK | ▲ Buy | Grant | 1,202 | $0 | 6/21/2023 | View on chart |
| ASAN | ▼ Sell | Open Market | 6,200 | $155K | 6/20/2023 | View on chart |
| ASAN | ▲ Buy | Grant | 7,753 | $0 | 6/12/2023 | View on chart |
| HUBS | ▲ Buy | Grant | 322 | $0 | 6/5/2023 | View on chart |
| CL | ▲ Buy | Grant | 2,220 | $0 | 5/15/2023 | View on chart |
| ASAN | ▲ Buy | Grant | 926 | $0 | 5/1/2023 | View on chart |
| CL | ▲ Buy | Grant | 359 | $26K | 4/3/2023 | View on chart |
| ASAN | ▲ Buy | Grant | 1,008 | $0 | 2/1/2023 | View on chart |
| CL | ▲ Buy | Option Exercise | 5,703 | $409K | 2/1/2023 | View on chart |
| CL | ▼ Sell | Open Market | 5,703 | $423K | 2/1/2023 | View on chart |
| CL | ▲ Buy | Grant | 271 | $21K | 1/3/2023 | View on chart |
| ASAN | ▲ Buy | Grant | 758 | $16K | 11/1/2022 | View on chart |
| CL | ▲ Buy | Grant | 280 | $21K | 10/3/2022 | View on chart |
| ASAN | ▲ Buy | Grant | 1,326 | $26K | 7/29/2022 | View on chart |
| CL | ▲ Buy | Grant | 273 | $21K | 7/1/2022 | View on chart |
| ADSK | ▲ Buy | Grant | 620 | $0 | 6/16/2022 | View on chart |
| ADSK | ▲ Buy | Grant | 1,521 | $0 | 6/16/2022 | View on chart |
| ASAN | ▲ Buy | Grant | 9,684 | $0 | 6/13/2022 | View on chart |
| HUBS | ▲ Buy | Grant | 430 | $0 | 6/7/2022 | View on chart |
| CL | ▲ Buy | Grant | 2,317 | $0 | 5/9/2022 | View on chart |
| ASAN | ▲ Buy | Grant | 1,327 | $36K | 4/29/2022 | View on chart |
| CL | ▲ Buy | Grant | 283 | $21K | 4/1/2022 | View on chart |
| CL | ▼ Sell | Open Market | 5,389 | $446K | 2/2/2022 | View on chart |
| CL | ▲ Buy | Option Exercise | 5,389 | $387K | 2/2/2022 | View on chart |
| ASAN | ▲ Buy | Grant | 326 | $17K | 1/31/2022 | View on chart |
| CL | ▲ Buy | Grant | 262 | $21K | 1/3/2022 | View on chart |
| ADSK | ▼ Sell | Open Market | 1,250 | $351K | 12/30/2021 | View on chart |
| ADSK | ▼ Sell | Open Market | 3,080 | $870K | 12/30/2021 | View on chart |
| ADSK | ▼ Sell | Open Market | 600 | $168K | 12/30/2021 | View on chart |
| HUBS | ▲ Buy | Option Exercise | 2,136 | $104K | 12/15/2021 | View on chart |
| HUBS | ▼ Sell | Open Market | 4,082 | $2.8M | 12/15/2021 | View on chart |
| ASAN | ▲ Buy | Open Market | 3,733 | $248K | 12/6/2021 | View on chart |
| ASAN | ▲ Buy | Grant | 114 | $15K | 10/29/2021 | View on chart |
| CL | ▲ Buy | Grant | 276 | $21K | 10/1/2021 | View on chart |
| ASAN | ▲ Buy | Grant | 167 | $12K | 7/30/2021 | View on chart |
| ASAN | ▲ Buy | Grant | 3,782 | $0 | 6/14/2021 | View on chart |
| ASAN | ▲ Buy | Grant | 357 | $12K | 4/30/2021 | View on chart |
| ASAN | ▲ Buy | Grant | 335 | $12K | 1/29/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Colgate-Palmolive dividend focus ahead of Q3 earnings call
Recent coverage lists Colgate‑Palmolive as a dividend champion and a contender for income‑focused investors. The company will host its 2026 third‑quarter earnings webcast on October 30, where results and guidance are expected. Investors noting the upcoming November 13 dividend should be aware of the October 20 record date to qualify for the payment. The stock continues to trade with a dividend yield of about 2.5%.
Colgate-Palmolive dividend focus ahead of Q3 earnings call. Recent coverage lists Colgate‑Palmolive as a dividend champion and a contender for income‑focused investors. The company will host its 2026 third‑quarter earnings webcast on October 30, where results and guidance are expected. Investors noting the upcoming November 13 dividend should be aware of the October 20 record date to qualify for the payment. The stock continues to trade with a dividend yield of about 2.5%.